Background & objectives: A major drawback for genetic studies as well as long-term genotype-phenotype correlation studies in cancer is lack of representative human cell lines providing a continuous source of basic biomolecules and a system to carry out various experimental investigations. This can be overcome to some extent by establishing lymphoblastoid cell lines (LCLs) by infecting peripheral blood lymphocytes with Epstein Barr virus (EBV) which is known to immortalize human resting B cells in vitro giving rise to actively proliferating B-lymphoblastoid cell lines. The present study involves preparation and characterization of LCLs generated from patients with multiple primary neoplasms (MPN) of upper aero-digestive tract (UADT).
Poster/oral presentations DNA repair and other gatekeeper mechanisms suggest aberrant gene-environment interactions to be an important aetiological factor in the genesis of multiple primary neoplasm (MPN) 3, 4 . Thus it is becoming increasingly important to validate the findings of huge number of genotyping studies in at least a subset of the patients by phenotypic assays. Short term studies to assay chromosomal aberrations, mutagen sensitivity assays and DNA repair kinetics have been carried out using lymphocytes or short term lymphocyte cultures derived from study population [5] [6] [7] . However, limited availability of biological material and lack of reproducibility has been the major limitation of such studies.
Immortalization of human B lymphocytes by Epstein Barr virus (EBV) in vitro is used routinely to establish lymphoblastoid cell lines (LCLs). Infection by EBV transforms resting B cells from human peripheral blood into actively proliferating LCLs 8 . Unlike SV40 or human papilloma virus (HPV), EBV allows cell immortalization with minimal genetic and phenotypic aberrations, with ease of establishment and maintenance making LCLs ideal material for genotypic and phenotypic studies 8 . These provide an unlimited source of biomolecules like DNA, RNA or proteins and are a promising in vitro model system for genetic screening studies, genotype-phenotype correlation studies, a variety of molecular and functional assays along with immunology and cellular biology studies [9] [10] [11] [12] . Utility of LCLs is also been very well documented in various population based studies especially investigating in vitro carcinogen sensitivity and DNA damage/ repair [13] [14] [15] . Here we report generation of 37 LCLs from patients with UADT MPN and healthy individuals and characterization of a few randomly selected cell lines.
Material & Methods
This study was approved by the Hospital Ethics Committee, Tata Memorial Centre, Mumbai and conducted during [2005] [2006] [2007] [2008] [2009] in the Mulherkar laboratory of Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, Maharashtra, India. Samples from healthy, age, sex and habit matched, control individuals were obtained from staff and students of ACTREC, Navi Mumbai.
Collection of samples:
After obtaining IRB approval and patient informed consent, 3 ml whole blood was collected in an EDTA vacutainer from patients with MPN and cancer free healthy individuals by venipuncture. Patients with MPN were accrued from the Cancer Genetics Clinic in Tata Memorial Hospital and samples from healthy control individuals were obtained from Advanced Center for Treatment Research and Education in Cancer, Mumbai, India. The study was approved by the Hospital Ethics Committee, Tata Memorial Hospital, Mumbai. UADT MPN patients were recruited on the basis of criteria given by Hong et al 16 as described earlier 17 .
Generation of viable EBV stock: EBV-transformed B95-8 marmoset cell line was procured from National Centre for Cell Sciences, India and the EBV stock prepared. Briefly, 0.5x10 6 cells/ml were seeded in RPMI-1640, 15 per cent foetal bovine serum (FBS) (Invitrogen, Carlsbad, CA), 200 mM glutamine (Sigma-Aldrich Co., USA) and 1X PenStrep (SigmaAldrich Co., USA). After 7 days confluent cultures of B95-8 appearing straw yellow in colour were lysed by freeze thawing at -80°C and 37°C and filtered through 0.22 μM filter (Millipore, Bedford, MA) to obtain EBV crude stock. The filtrate was aliquoted and stored at 4°C for short term or -80°C for long-term storage.
Lymphoblastoid cell line preparation: For separation of peripheral blood lymphocytes (PBLs) approximately 3 ml of blood was separated on a Ficoll-Hypaque gradient (Sigma-Aldrich Co., USA). PBLs were seeded in a sterile 24 well plate at a density of 1.5-2x10 6 cells/ ml in Dulbecco's minimal essential medium (DMEM) containing 15 per cent FBS 200 m M glutamine and IX Pen Strep. EBV crude stock at 1:1 ratio was added and placed in an incubator maintained at 37°C with 5 per cent CO 2 . After 24 h medium containing viral supernatant was aspirated without disturbing the cells and fresh complete DMEM was added. After 3-4 wk of incubation rosette morphology of cells ascertained the transformed phenotype of PBLs. Cells were mixed thoroughly to break clumps before splitting to ensure multiclonal population. All the used plasticware (Nunc, Denmark) was treated as biohazard, discarded in 1 per cent sodium hypochlorite after use and autoclaved wherever required.
Characterization of LCL:
Characterization of LCLs was done using standard techniques as described below. For all assays freshly grown cells with >90 per cent viability were harvested and washed in 1X PBS at 1500 rpm and used for the genotypic and phenotypic characterization.
Immunophenotyping: 1x10 6 cells from LCLs were incubated with primary mouse anti-CD3 (T cell marker), anti-CD19 (pan-B cell marker) and anti-CD56 (NK cell marker) antibodies (BD Pharmingen, BD Biosciences, USA) for 45 min on ice. The cells were washed thrice with FACS buffer (PBS containing 1% FBS and 0.02% Na-azide) and incubated for 45 min on ice with secondary goat anti-mouse FITC antibody (antibodies used in this experiment were kind gift from Dr Shubhada Chiplunkar and Dr Naren Joshi, Immunology department, ACTREC). Cells were passed through BD TM 1ml 26G ½ syringe (BD, Singapore) to break any cell aggregates or clumps and analyzed on Flow Cytometer (FACS Calibur, BD Biosciences, USA) at 488 nm excitation. A minimum of 10,000 events were analyzed for each sample. Cellular debris was removed by gating on Forward vs. Side Scatter. Statistical analysis was done using CELLQUEST software (BD Biosciences, USA).
Ploidy analysis of LCLs: LCLs (1x10 6 ) and control PBLs (1x10 6 ) from healthy volunteer were fixed in 70 per cent ethanol at 4°C for 1 h. The cells were washed twice in PBS followed by incubation with propidium iodide (Sigma-Aldrich Co., USA) and RNaseA (SigmaAldrich Co., USA) for 30 min at 37°C. Fluorescence was acquired on Flow Cytometer at 488 nm excitation. Cells were passed through BD TM 1ml 26G ½ syringe before acquisition to break any cell aggregates or clumps and a minimum of 10,000 events were analyzed for each sample. Data were analyzed using ModFit LT V 2.0 software (BD Biosciences, USA). DNA ploidy is defined as diploid DNA represented as single G0/ G1 peak on a histogram corresponding to the same DNA content represented as single G0/G1 at the same position in the histogram of the control. Ploidy was measured by calculating DNA index (DI) which is the ratio between the channel number of G0/G1 peak on histogram of the cell line to the channel number of G0/ G1 peak of control PBLs.
Expression of ATM gene: RNA was isolated from cell lines and lymphocytes isolated from the same subjects by TRIzol (Invitrogen, Carlsbad, CA) extraction method. β actin PCR 18 was performed on isolated RNA to ensure any DNA contamination and samples were treated with DNase using DNA-free kit (Ambion, Austin, TX) wherever required. cDNA was synthesized using 3 μg of total RNA using Superscript First-Strand synthesis system by RT-PCR (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. Expression of ATM gene was measured semi-quantitatively by RT-PCR using gene specific primers (Sigma-Aldrich Co., India; Forward 5'-TGTCATTACGTAGCTTCTCC-3'; Reverse 5'-GCTGAGTAATACGC AAATCC-3) and β actin was used as loading control. PCR products were run on 2 per cent agarose gel and stained with ethidium bromide.
Cell population doubling: 5x10
4 cells from LCLs were seeded in a 24 well plate with 1.5 ml of complete medium. Viable cell count was taken using Trypan blue dye exclusion method 19 at different time points including 0, 12, 24, 36, 48, 72 and 96 h. For each time point four readings were taken.
Results

Establishment of LCLs and morphological analysis:
Blood samples from MPN patients (n=24) and cancer free control individuals (n=13) were obtained and subjected to LCL preparation. The demographics of the patients and control individuals are shown in Table  I . Considerable cell death of the PBLs was observed after 24 h post EBV infection; however, virus infection promoted B cells to re-populate the culture. The time taken for each LCL preparation varied. On an average culturing the cells 3-4 wk post infection was sufficient to produce >1 million cells.
The average population doubling (PD) time of a few representative LCLs was found to be 24 h, ranging from 12 to 36 h (Fig. 1) . The LCLs grew as clusters exhibiting typical rosette morphology in suspension cultures, but single cells were also observed having big nucleus and numerous vacuoles (Fig. 2a, 2b) . EBV is known to specifically infect B cells allowing their growth in culture hence the transformed phenotype is expected to have homogeneous cell population, however, flow cytometric analysis revealed the presence of dual population (Fig. 2c) . On the basis of morphology and granularity it was revealed that lower (R1) population represents mono cell suspension of interest and the other (R2) population probably represents fraction of cells that have spontaneously differentiated into smaller lymphoid cells with shrunken nucleus that ultimately undergo apoptosis during conventional cell culture thus representing diverse size and granularity 20 .
Cell surface marker: Immunophenotyping was done using PBL as positive control for B (CD19), T (CD3) and NK (CD56) cells. Data confirmed that cells from representative randomly selected LCLs showed expression of typical B cell surface marker (CD19) while markers for T cell (CD3) and NK cells (CD56) were absent ( Fig. 3) , thus ascertaining the purity of growing cultures. DNA ploidy analysis: DNA ploidy status of the LCLs was assessed immediately after cell line preparation at low population doubling (<5 PD) using PBL from healthy individuals as diploid control. A shift in the position of the diploid peak of LCL away from the expected diploid position of the control can be taken as an evidence of DNA aneuploidy. All the cell lines studied had DI values ranging between 0.8-1.3 and were considered diploid (Table II, The DI values ranged between 0.93 and 1.18; hence were considered to be diploid (Table III) .
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Expression and activity of ATM gene: Lytic cycle of EBV elicits a cellular DNA damage response resulting in activation of the ataxia telangiectasia-mutated (ATM) signal transduction pathway 21 ; hence ATM expression in the cell lines and their respective PBL was studied. There was apparently no change in the expression level of ATM gene between the LCL and respective PBL from the subject (Fig. 5) . The number of pATM Ser1981 foci seen as distinct nuclear foci in response to cellular DNA damage, were similar in both -the cell line as well as lymphocytes (data not shown).
Discussion
We report here generation and characterization of LCLs from MPN patients and healthy individuals. LCLs can be generated efficiently as continuously growing cells from an individual following infection of PBLs with EBV-containing supernatants. Such EBV immortalized cells are derived from B lymphocytes and, unlike cell lines derived from other tissues, remain near diploid in nature. Such LCLs can be used for various in vitro studies as well as serve as a source of DNA for genomic studies. Generation of EBV transformed cell lines has proven to be cost-effective, rapid and reliable with minimal deviation from the normal phenotype and genotype.
B95-8 cells derived from Marmoset lymphocytes, infected and immortalized with EBV, are typically used for virus production since these spontaneously . Hence, in the present study, for phenotypic assays LCLs were used within 45-60 PD. Cell immortalization and proliferation in continuous cultures can result in aberrant DNA changes like aneuploidy or tetraploidy. Hence ploidy status of the cell lines was ascertained at both, low and high population doublings ranging from <5 to >100 PD taking normal PBL as control. DNA index (DI) ratio was calculated to establish the ploidy status. DI ratio of 1 was considered as diploid 23 while DI values ranging from 1.9-2.1 with proportion of cells greater than the G2/M fraction of normal control, after correction of the aggregates were considered as tetraploid 24 . All the cell lines studied at lower (<5 PD) as well as higher population doubling (>100 PD) had a DI ratio ranging between 0.9-1.3 and were considered to be diploid.
Morphological analysis of cell lines by flow
As described in earlier reports EBV remains episomal in lymphoblastoid cell lines maintaining a latent infection, although there is a small subpopulation of cells that switches spontaneously from a latent stage of infection into the lytic cycle. Induction of EBV lytic replication elicits cellular DNA damage response dependent on ATM 19 . DNA damage sensor MRN (Mre II, Rad 50 and Nbsl) complex and phosphorylated ATM are recruited to viral replication compartments, presumably recognizing newly synthesized viral DNAs as abnormal DNA structures 21 . The LCLs in the present study were established with an aim to eventually study the contribution of DNA damage repair in vitro in UADT MPN patients and to elucidate the mechanism involved. Hence it was necessary to ensure that the process of EBV transformation did not affect expression and activity of DNA repair gene ATM. It was observed that EBV transformation did not elicit DNA repair pathway dependent on ATM as there were no pATM foci seen in LCLs (data not shown). This was further confirmed by measuring γH2AX foci in cell lines which was also found to be negative (data not shown). Also there was no change in ATM gene expression in cell lines and PBLs as revealed by semiquantitative RT PCR data.
This property of LCLs to be able to grow in continuous culture together with maintaining a close similarity to the parent lymphocytes has been exploited in various studies. There are numerous reports where LCLs have been used as a source of basic biomolecules like, DNA, including mitochondrial DNA, RNA and protein 9 . DNA isolated from LCLs has been widely used for mutation analysis 25, 26 , while RNA isolated from these cell lines has been commonly used for cDNA library preparation and to assess transcriptional response to genotoxins using high throughput technologies including cDNA microarray 27 , together with this LCLs have as well been used for proteomic studies 28 .
For large scale population based studies, LCLs provide a constant supply of starting material for a variety of assays, sparing the need of re-sampling. LCLs have been established as an excellent model system not only in basic biomedical studies but also to carry out genomic wide high throughput research thus showing their utility in a broad range of biomedical research 29, 30 . All this emphasizes the research utility of LCLs as a surrogate for isolated lymphocytes. The cell lines developed in the present study have been well characterized and provide a valuable, cost effective, in vitro model system for genotypic and phenotypic assays ensuring adequate starting material for current and future analysis.
Abstract: Background. Fanconi's anemia (FA) is a rare autosomal recessive genetic disorder characterized by congenital anomalies, progressive aplastic anemia, and a predisposition for malignancies. Solid tumors in the head and neck region, especially in the tongue, are rarely observed. Management of these patients is a challenge because of hematological complications and increased toxicities.
Methods. We report a case of Fanconi's anemia in a 27-year-old man with carcinoma of the base of tongue (T2N0M0) who was treated with radical radiation therapy to a dose of 70 Gy/35 fractions/51 days. We have also done in vitro radiosensitivity tests.
Results. The patient tolerated the radiation treatment well and completed it without any interruptions. In vitro studies did not show any increased radiosensitivity in this patient. Keywords: Fanconi's anemia; base of tongue; radiation therapy; head and neck cancer; radiosensitivity Fanconi's anemia (FA) is a rare autosomal recessive genetic disorder characterized by congenital anomalies, progressive aplastic anemia leading to pancytopenia, and a predisposition for malignancies. 1 Congenital anomalies in FA clinically manifest as skeletal, renal, ophthalmological malformations, and chromosomal aberrations. The disease involves multiple organs that include skin, genitourinary, musculoskeletal, renal, and neurological systems. The clinical findings in FA patients are abnormal skin pigmentation like café au lait spots, abnormal male gonads (absent, atrophic, or abnormal testis, hypospadias, undescended testis), microcephaly, short stature, hypoplastic thumb with or without radial anomalies, renal defects, and developmental delay, mental retardation, and learning disability. 2, 3 FA is associated with increased risk of malignancies, and the risk further increases with bone marrow transplantation, which is done for treatment of hemopoietic failure associated with the disease. 4, 5 The cause of development of cancer in FA is thought to be attributable to a defect in maintaining the genome integrity, leading to increased chromosomal instability with defective DNA repair mechanism. [6] [7] [8] Although hematological malignancies are 1 of the most common cancers, solid tumors in the head and neck region, especially in the tongue, are also observed. [9] [10] [11] Management of cancers in the head and neck region in patients with FA is challenging. Surgery, although considered as an optimal treatment, has its limitations as a result of low counts, risk of infection, and wound-healing issues. 9, 12 Radiation therapy or chemotherapy is associated with increased risk of toxicity in these patients because of defective DNA repair mechanism. 9, 13, 14 There have been instances of variable clinical radiosensitivity and fulminant radiation toxicities even with low doses of radiation. [13] [14] [15] Therefore, in vitro sensitivity studies, although not common, have been performed on fibroblast cells or peripheral blood mononuclear cells to predict the in vivo radiation sensitivity. 15, 16 We report a case of a young man with FA who was diagnosed with carcinoma of the base of tongue and was treated with radical radiation therapy. We also report the results of an in vitro test for radiosensitivity in our patient and review the literature for FA patients with head and neck cancer.
CASE REPORT
A 27-year-old man was referred to our hospital for evaluation of a base-of-tongue lesion that had appeared 3 months earlier. Oral examination revealed a well-circumscribed, ulceroproliferative lesion on the left side of the base of tongue measuring 2.5 cm in diameter. Neck examination showed no cervical lymphadenopathy. On general physical examination, he was physically retarded (short stature, microcephaly, and microophthalmia) with atrophic testis and a few café au lait spots on skin, particularly of the lower extremities.
MRI showed a well-localized soft tissue mass on the base of tongue (left > right), with no significant cervical lymphadenopathy ( Figures 1A  and 1B) . The histopathology review showed squamous cell carcinoma. Therefore, a diagnosis of carcinoma of the base of tongue, T2N0M0 (stage II), was made. The complete blood count, showed features of generalized pancytopenia (total leukocyte count, 1.8 Â 10 9 /L; hemoglobin, 7.1 gm/dL; and platelets, 17 Â 10 9 ). Complete blood count was repeated but pancytopenia persisted. The patient underwent a bone marrow aspiration and biopsy, which revealed hypocellular marrow. In view of his abnormal morphological features and unexplained hypocellular marrow, the patient was advised for chromosomal studies. Subsequently, chromosomal breakage analysis was done in peripheral blood lymphocytes in the presence of DNA crosslinking agents, diepoxybutane (DEB) and mitomycin C (MMC), which revealed a high frequency of chromosomal breakage (6.2 chromosome breaks per metaphase) compared with control (1.3 breaks per metaphase). Increased frequency of radial formation was also observed in this patient compared with controls ( Figure 2) . Bone marrow chromosomal analysis further revealed chromosomal aberrations. Finally, diagnosis of FA was made on the basis of clinical features, hematological picture, and chromosomal breakage analysis.
Hematological parameters precluded surgical interventions and chemotherapy. It was therefore decided to treat him with radical external beam radiation therapy. Radiation to the face and regional lymph nodes was started with conventional fractionation of 200 cGy/day once daily and 5 days/week schedule using bilateral parallel opposed portals. In week 4 of radiation, a nasogastric tube was inserted to improve the nutritional support. The patient was admitted after completion of 54 Gy, given that his total leukocyte count was 2.1 Â 10 9 /L and he developed fever. Broad-spectrum injectable antibiotics were started, along with granulocyte colony stimulating factor. He successfully completed the treatment to a total dose of 70 Gy/35 fractions over 51 days with reducing portals respecting the tolerances of critical structures. The treatment was completed without any interruptions. At the conclusion of treatment, he had Radiation Therapy Oncology Group (RTOG) grade 3 toxicity of skin and mucosa. His count was consistently low, for which he was kept on intensive supportive care. Admission was required because of systemic effects, and not because of radiation reaction. He was eventually discharged from the hospital after 4 weeks, when his fever had subsided but pancytopenia persisted.
In vitro study was done to determine the radiosensitivity by radiating peripheral blood mononuclear cells (PBMCs) isolated from blood to increasing doses of radiation. The rate of apoptosis in this patient was compared with a matched control. At each radiation dose as well as in the unirradiated sample, FA had more live cells than that of control. Spontaneous rate of apoptosis (ie, apoptosis at 0 Gy) was found to be less in this case of FA. The percentage of early apoptotic cells increased from 9% to 30% in the case of an FA patient with an increase in radiation dose from 0 Gy to 25 Gy compared with control, in which it increased from 14% to 48%. The percentage of late apoptotic cells was also found to be low in the case of the FA patient, which increased from 2% to only 5%, which in the case of control reached 14%. This experiment suggested that radiation-induced apoptosis was less in our patient. We also studied the percentage of necrotic cells and observed that the percentage of necrotic cells was greater in the case of the FA patient compared with control. Necrotic cells increased from 1.5% to 12% in the case of the FA patient, compared with control, in which they remained <2% at each radiation dose, suggestive of cell death attributed to the necrotic inflammatory pathway in the FA patient, making them more radiosensitive.
The patient was followed up at 6 weeks postradiation therapy, when he was evaluated for local control and toxicities. The radiation reactions of skin and mucosa had settled and there was no clinical evidence of disease. A follow-up evaluation at 3 months postradiation therapy revealed similar findings. An MRI scan showed evidence of level IV lymph node. This lymph node was not present in the preradiation therapy scan. Fine-needle aspiration cytology from this node showed the presence of squamous carcinoma. Opinion was taken for surgical salvage but was not considered because of fixation to surrounding structures, low counts, and the risk associated with surgery because of his FA. He was therefore considered for palliative reirradiation with electrons, which he completed with good symptom relief. He was alive with disease at his last follow-up, which was 14 months after his initial diagnosis.
DISCUSSION
FA is an autosomal recessive disorder associated with bone marrow suppression, congenital anomalies, and high risk of malignancies. 17 It has been hypothesized that the malignancies occur either because of chromosomal instability or because of immunodeficiencies. 18 Although the association of FA with malignancies was described in 1927, cancer of the head and neck region was reported in 1966 by Esparza and Thompson. 3 Hematological malignancies are the most common malignancies seen in patients with FA, followed by solid tumors, especially head and neck cancers. 9 In a large study of 1300 patients with FA, the incidence of solid tumors was around 5%. 19 In a review of 754 patients from the International Fanconi's Anemia Registry, 3% patients had head and neck cancer. 20 This incidence was significantly higher compared with that of the normal population. 9 Although the data on ethnic origin of these patients are not very clear, there is a scarcity of data from Asian countries. This is thus 1 of the important case reports in an Indian male patient.
The median age of onset of tumors in patients with FA is as early as 16 to 31 years in different series. 12, 19 In our patient, the age of onset was at 27 years, which was much earlier compared with the median age of 56 years in our population for head and neck cancer. In our patient, the diagnosis of malignancy was made before that of FA. His routine investigations showed pancytopenia, which led to further investigations, such as bone marrow biopsy and chromosomal studies, which eventually confirmed the diagnosis of FA. Surgery has been considered as the primary modality of treatment in many patients with FA. 12 Of the 19 patients with head and neck cancer in the International FA Registry, 17 have undergone primary surgery. Surgery in these patients was well tolerated. 9 It has been suggested that surgery should be encouraged in these patients, to prevent the issues associated with chemotherapy and irradiation. 9, 13, 14, 20 Chemotherapy-associated with very high morbidity attributed to DNA damage and impaired repair mechanism-was thus not considered in our patient. In addition, this patient had stage II low-volume disease; therefore single-modality treatment in the form of radiation therapy was considered. Use of alkylating agents that crosslink DNA can have serious adverse effects in these patients.
14 Furthermore, chemotherapy is also known to cause a deleterious effect of myelosupression in patients with baseline bone marrow suppression. 9, [12] [13] [14] There have been varying reports of tolerance to radiation therapy in cancer patients with FA and there appears to be increased radiosensitivity in these patients. 13, 14 This could possibly be ascribed to an increase in chromosomal breakage and impaired cell repair mechanisms. 9, 13, 14, 16 In 1 of the reported cases, the radiation mucositis was observed as early as 3.2 Gy, whereas in another patient radiation was delivered without much toxicity. 12 Marcou et al 15 reported a patient with tonsillar cancer who developed unusually brisk reactions after 24 Gy. Varying doses of radiation have been documented in the literature, ranging from 3.2 Gy to 80 Gy. Overall, radiation has been associated with increased normal tissue toxicity, delayed healing, and increased supportive care.
FA along with ataxia telangiectasia, Bloom's syndrome, and xeroderma pigmentosum are called cancer breakage syndromes because they are associated with chromosomal instability and defective repair, thereby predisposing to development of cancers. 15 Cells from FA show variable levels of cellular radiosensitivity, and results of an in vitro experimental study done for predicting the hypersensitive response may not coincide with in vivo radiosensitivity results. 21, 22 Various experimental techniques including alkaline single-cell gel electrophoresis (Comet assay), colony-forming test, Western blot, and foci immunofluorescence analysis of the expression of DNA repair proteins, and also the cytochalasin-blocked micronuclei (MN) test using FA fibroblasts have been adopted to correlate the in vitro radiation sensitivity with the outcome of therapy. 23, 24 However, the limitation of these techniques is the 4-week delay required for colony growth. 15, [25] [26] [27] Comet assay is widely regarded as a robust and informative method for radiosensitivity measurements immediately after DNA damage, 28, 29 but it is only a qualitative assessment of the response. Western blot and foci immunofluorescence analysis give qualitative results, but are labor intensive and also lack correlation between in vitro results and in vivo radiation response. 28 In view of the conflicting data on radiosensitivity of FA cells, and particularly FA fibroblasts, there is a pressing need for the development of new rapid and predictive assays of radiation responses. We have performed our study on PBMCs isolated from blood. Compared with most of the previous studies using fibroblasts, collecting blood has an advantage over invasive procedures of obtaining fibroblasts from patients' skin biopsies, avoids time-consuming methods of generating monolayer cultures, and is also less labor intensive.
Clinical radioresponsiveness is unpredictable in patients of FA with cancer, especially of the head and neck region, and outcome varies.
14 Of the 19 patients in the International FA Registry who had head and neck cancer, 14 died because of disease. The median time to recurrence in their patients was 16 months and the median follow-up of surviving patients was 19 months. 9 Kennedy and Hart 30 noted multiple primary malignancies either synchronous or metachronous in patients with FA to the extent of 36% (5 of 14 patients). Our patient developed a lymph node at level IV at 3 months follow-up and was alive with disease at 14 months.
There are no standard guidelines for management of FA patients with malignancies. This is primarily a result of the scarcity of data and heterogeneous population. 13 It has therefore been recommended that more data in the form of case reports should be encouraged. 13 Until then, the treatment of patients with malignancies with FA should be individualized. Any decision about opting for different modalities should be based on a balanced approach with respect to locoregional control and toxicities of the treatment.
